Valerie Weaver: Overcoming cancer's stiff resistance
نویسندگان
چکیده
منابع مشابه
Valerie Weaver: Overcoming cancer's stiff resistance
E ach year in the United States alone, more than 200,000 cases of breast cancer are diagnosed. Most women fi nd their tumors on their own, by feeling a lump in their breast. Tumors can be detected in this way because they are stiffer than normal tissue, explains Valerie Weaver, Director of UCSF's Center for Bioengineering and Tissue Regeneration. This stiffness is both a consequence and a cause...
متن کاملOvercoming antiangiogenic resistance.
The success of drugs targeting angiogenesis is tempered by the transient duration of disease control and modest survival improvement. The very hypoxic stress produced by successful therapy may lead to upregulation of multiple pathways that promote angiogenesis and invasive behavior. Overcoming this evasive resistance may further improve outcome.
متن کاملValerie Schmidt
Introduction We have all heard the old joke of school being all about the three “R’s”, Reading ‘Ritin and ‘Rithmatik, but because of increasing class sizes and reported lack of instruction time, writing has been passed over for the more “important” subjects. The advent of computers and the increasing ease of word processing have given teachers the ultimate excuse, but most beginning composition...
متن کاملOvercoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
Using transgenic mouse models, cell line-based functional studies, and clinical specimens, we show that cyclin D1/CDK4 mediate resistance to targeted therapy for HER2-positive breast cancer. This is overcome using CDK4/6 inhibitors. Inhibition of CDK4/6 not only suppresses Rb phosphorylation, but also reduces TSC2 phosphorylation and thus partially attenuates mTORC1 activity. This relieves feed...
متن کاملNovel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers
Gastrointestinal (GI) cancers, such as of the colon and pancreas, are highly resistant to both standard and targeted therapeutics. Therapy-resistant and heterogeneous GI cancers harbor highly complex signaling networks (the resistome) that resist apoptotic programming. Commonly used gemcitabine or platinum-based regimens fail to induce meaningful (i.e. disease-reversing) perturbations in the re...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cell Biology
سال: 2011
ISSN: 1540-8140,0021-9525
DOI: 10.1083/jcb.1935pi